Paying for Cures:

Self-Insured Employers Workshop

Learn innovative financing strategies to make cell and gene therapies accessible
and sustainable.

 
Image

Paying for Cures:

Self-Insured Employers Workshop

Learn innovative financing strategies to make cell and gene therapies accessible
and sustainable.

Durable, potentially curative therapies for genetic disorders and cancer have arrived. Short—even single dose—treatment regimens yield lasting health benefits, but large single payments will challenge the current reimbursement system.

In this virtual workshop the FoCUS Project will help you explore the impact of cell and gene therapies on your health benefit plans, survey the risks, and learn about solutions.

June 17, 2021 

11:00am – 3:00pm Eastern via Web conference

Register now

Registration is free

This intensive 1-day virtual workshop will help you: 

  • Understand how these therapies are different
  • Explore new solutions and support resources
  • Discover actionable and affordable steps to ensure sustainable coverage and access

Ideal for:

  • Self-insured employer health benefits and finance professionals
  • Other advisors and partners such as self-insured employer brokers, consultants and stop-loss carriers
Image Image Image

Program overview

Agenda details to come

Framing the Issues: Definition of cell and gene therapies and their unique challenges/risks for self-insured employers

Drug development pipeline: Currently approved treatments and near-term pipeline of expected products

Implications for stop-loss coverage

New commercial solutions to address the unique challenges of cell and gene therapies

Actions self-insured employers can take today

Agenda

Welcome and introductions

Mark Trusheim, Strategic Director, NEWDIGS; FoCUS Project Lead; Visiting Scientist at MIT Sloan School of Management
Gigi Hirsch, Executive Director, MIT Center for Biomedical Innovation (CBI); Director, NEWDIGS Initiative at MIT

Framing the Issues
Definition of Cell and Gene Therapies and their unique challenges/risks for self-insured employers including toolkit.

Mark Hansan, President and CEO, CareMetx

Drug development pipeline
Currently approved treatments and near-term pipeline of expected products

Colin Young, Director, Drug Development Pipeline Research, NEWDIGS FoCUS Project

Implications for stop-loss coverage

Jane Barlow, Senior Advisor, NEWDIGS FoCUS Project and Moderator

New commercial solutions

Jane Barlow, Senior Advisor, NEWDIGS FoCUS Project and Moderator

PANEL & DISCUSSION

Actions self-insured employers can take today

Jane Barlow, Senior Advisor, NEWDIGS FoCUS Project and Moderator

Recap and conclusion

Mark Trusheim, Strategic Director, NEWDIGS; FoCUS Project Lead; Visiting Scientist at MIT Sloan School of Management

Speakers

Additional speakers TBA

Image

Jane F. Barlow, MD, MBA, MPH
CEO, Jane Barlow & Associates; 
EVP and Chief Clinical Officer, Real Endpoints; 
Senior Advisor, MIT Center for Biomedical Innovation, NEWDIGS

Image

Mark Trusheim, MS
Strategic Director, NEWDIGS;
Visiting Scientist, Sloan School of
Management,
Massachusetts Institute of Technology

Image

Cynthia J. Pigg, BSMT, BSPharm, MHA, FAMCP
Senior Vice President, Commercial Market Leader, Pharmacy

Image

Michelle Harika, PharmD
Chief Clinical Officer for Equity Healthcare

Agenda

Welcome and introductions

Mark Trusheim, Strategic Director, NEWDIGS; FoCUS Project Lead; Visiting Scientist at MIT Sloan School of Management
Gigi Hirsch, Executive Director, MIT Center for Biomedical Innovation (CBI); Director, NEWDIGS Initiative at MIT

Framing the Issues
Definition of Cell and Gene Therapies and their unique challenges/risks for self-insured employers including toolkit.

Mark Hansan, President and CEO, CareMetx

Drug development pipeline
Currently approved treatments and near-term pipeline of expected products

Colin Young, Director, Drug Development Pipeline Research, NEWDIGS FoCUS Project

Implications for stop-loss coverage

Jane Barlow, Senior Advisor, NEWDIGS FoCUS Project and Moderator

New commercial solutions

Jane Barlow, Senior Advisor, NEWDIGS FoCUS Project and Moderator

PANEL & DISCUSSION

Actions self-insured employers can take today

Jane Barlow, Senior Advisor, NEWDIGS FoCUS Project and Moderator

Recap and conclusion

Mark Trusheim, Strategic Director, NEWDIGS; FoCUS Project Lead; Visiting Scientist at MIT Sloan School of Management

Registration

June 17, 11:00am – 3:00pm
Zoom Web conference
Registration is free

Register now